| No Secondhand Smoke Exposure in Never-Smoking Adult Cancer Survivors (N = 591) | Secondhand Smoke Exposure in Never-Smoking Adult Cancer Survivors (N = 239) |
---|---|---|
Hypertension (2017 AHA/ACCa) | ||
 Model 1 | 1.00 (Ref) | 1.29 (0.88–1.89) |
 Model 2 | 1.00 (Ref) | 1.31 (0.89–1.93) |
 Model 3 | 1.00 (Ref) | 1.33 (0.90–1.96) |
General obesityb | ||
 Model 1 | 1.00 (Ref) | 1.47 (0.98–2.22) |
 Model 2 | 1.00 (Ref) | 1.47 (0.97–2.23) |
 Model 3 | 1.00 (Ref) | 1.47 (0.97–2.22) |
Abdominal obesityb | ||
 Model 1 | 1.00 (Ref) | 1.20 (0.82–1.75) |
 Model 2 | 1.00 (Ref) | 1.19 (0.81–1.74) |
 Model 3 | 1.00 (Ref) | 1.20 (0.82–1.75) |
Hyperlipidemiac | ||
 Model 1 | 1.00 (Ref) | 0.99 (0.67–1.47) |
 Model 2 | 1.00 (Ref) | 1.02 (0.67–1.54) |
 Model 3 | 1.00 (Ref) | 1.03 (0.68–1.55) |
Hypertriglyceridemiac | ||
 Model 1 | 1.00 (Ref) | 1.63 (1.08–2.46)* |
 Model 2 | 1.00 (Ref) | 1.62 (1.06–2.47)* |
 Model 3 | 1.00 (Ref) | 1.63 (1.07–2.48)* |
Reduced HDL-Cc | ||
 Model 1 | 1.00 (Ref) | 1.04 (0.72–1.49) |
 Model 2 | 1.00 (Ref) | 0.99 (0.69–1.43) |
 Model 3 | 1.00 (Ref) | 1.01 (0.70–1.45) |
Impaired fasting glucose (ADA/WHOd) | ||
 Model 1 | 1.00 (Ref) | 1.07 (0.73–1.58) |
 Model 2 | 1.00 (Ref) | 1.06 (0.71–1.57) |
 Model 3 | 1.00 (Ref) | 1.07 (0.72–1.58) |